These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
626 related articles for article (PubMed ID: 19666944)
1. Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors. Karim RZ; Li W; Sanki A; Colman MH; Yang YH; Thompson JF; Scolyer RA Int J Surg Pathol; 2009 Oct; 17(5):361-7. PubMed ID: 19666944 [TBL] [Abstract][Full Text] [Related]
2. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma. Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257 [TBL] [Abstract][Full Text] [Related]
3. Proteins involved in pRb and p53 pathways are differentially expressed in thin and thick superficial spreading melanomas. de Sá BC; Fugimori ML; Ribeiro Kde C; Duprat Neto JP; Neves RI; Landman G Melanoma Res; 2009 Jun; 19(3):135-41. PubMed ID: 19369901 [TBL] [Abstract][Full Text] [Related]
4. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions. Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395 [TBL] [Abstract][Full Text] [Related]
5. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis. Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423 [TBL] [Abstract][Full Text] [Related]
6. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma. Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727 [TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Reed JA; Loganzo F; Shea CR; Walker GJ; Flores JF; Glendening JM; Bogdany JK; Shiel MJ; Haluska FG; Fountain JW Cancer Res; 1995 Jul; 55(13):2713-8. PubMed ID: 7796391 [TBL] [Abstract][Full Text] [Related]
9. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lai S; El-Naggar AK Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061 [TBL] [Abstract][Full Text] [Related]
11. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. Wang Y; Becker D Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798 [TBL] [Abstract][Full Text] [Related]
12. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in melanocytic lesions of the skin. Ramirez JA; Guitart J; Rao MS; Diaz LK Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449 [TBL] [Abstract][Full Text] [Related]
14. Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue. Krecicki T; Smigiel R; Fraczek M; Kowalczyk M; Sasiadek MM J Laryngol Otol; 2004 Sep; 118(9):676-80. PubMed ID: 15509364 [TBL] [Abstract][Full Text] [Related]
15. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. Li Q; Murphy M; Ross J; Sheehan C; Carlson JA J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322 [TBL] [Abstract][Full Text] [Related]
16. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495 [TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532 [TBL] [Abstract][Full Text] [Related]
19. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma. Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753 [TBL] [Abstract][Full Text] [Related]
20. Expression of p16 and lack of pRB in primary small cell lung cancer. Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]